Abstract
Doxorubicin is one of the most effective chemotherapeutic agents currently available. However, its use has been limited by its cardiotoxic effect, especially when used for a long time, leading to iatrogenic cardiomyopathy, related to the cumulative dose administered. Because of the refractoriness of the cardiotoxic effects resulting from the treatment with doxorubicin, its prevention play…